TLP
MRTX

Tri Locum Partners’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Tri Locum Partners’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-24,201
Closed -$874K – 90
2023
Q2 		$874K Buy
+24,201
New +$874K 0.33% 39
2023
Q1 		– Sell
-104,598
Closed -$4.74M – 88
2022
Q4 		$4.74M Sell
104,598
-46,936
-31% -$2.13M 1.92% 19
2022
Q3 		$10.6M Buy
+151,534
New +$10.6M 2.9% 13